{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:51:21Z","timestamp":1777614681670,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00066-023-02086-6","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:01:41Z","timestamp":1685534501000},"page":"676-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-350X","authenticated-orcid":false,"given":"Savino","family":"Cilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Arcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milly","family":"Buwenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"11","key":"2086_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman\u00a0R, Paulus\u00a0R, Galvin\u00a0J et\u00a0al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303(11):1070\u20131076. https:\/\/doi.org\/10.1001\/jama.2010.261","journal-title":"JAMA"},{"issue":"14","key":"2086_CR2","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3390\/cancers13143623","volume":"13","author":"G Virbel","year":"2021","unstructured":"Virbel\u00a0G, Le F\u00e8vre\u00a0C, No\u00ebl\u00a0G, Antoni\u00a0D (2021) Stereotactic body radiotherapy for patients with lung oligometastatic disease: a five-year systematic review. Cancers 13(14):3623. https:\/\/doi.org\/10.3390\/cancers13143623","journal-title":"Cancers"},{"key":"2086_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lungcan.2011.04.021","volume":"75","author":"U Ricardi","year":"2012","unstructured":"Ricardi\u00a0U, Filippi\u00a0AR, Guarneri\u00a0A, Ragona\u00a0R, Mantovani\u00a0C, Giglioli\u00a0F et\u00a0al (2012) Stereotactic body radiation therapy for lung metastases. Lung Cancer 75:77\u201381. https:\/\/doi.org\/10.1016\/j.lungcan.2011.04.021","journal-title":"Lung Cancer"},{"key":"2086_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/02841860600908954","volume":"45","author":"P Okunieff","year":"2006","unstructured":"Okunieff\u00a0P, Petersen\u00a0AL, Philip\u00a0A, Milano\u00a0MT, Katz\u00a0AW, Boros\u00a0L et\u00a0al (2006) Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol 45:808\u2013817. https:\/\/doi.org\/10.1080\/02841860600908954","journal-title":"Acta Oncol"},{"key":"2086_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","volume":"91","author":"JJ Nuyttens","year":"2015","unstructured":"Nuyttens\u00a0JJ, van der Voort van Zyp\u00a0NCMG, Verhoef\u00a0C, Maat\u00a0A, van Klaveren\u00a0RJ, van der Holt\u00a0B et\u00a0al (2015) Stereotactic body radiation therapy for oligometastases to the lung: a\u00a0phase 2\u00a0study. Int J Radiat Oncol Biol Phys 91:337\u2013343. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.10.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2086_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamaoncol.2018.6993","volume":"5","author":"DA Palma","year":"2019","unstructured":"Palma\u00a0DA, Nguyen\u00a0TK, Louie\u00a0AV et al (2019) Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non-small cell lung cancer: a\u00a0phase 2 clinical trial. JAMA Oncol 5:681\u2013688. https:\/\/doi.org\/10.1001\/jamaoncol.2018.6993","journal-title":"JAMA Oncol"},{"issue":"10","key":"2086_CR7","first-page":"5581","volume":"35","author":"R Frakulli","year":"2015","unstructured":"Frakulli\u00a0R, Salvi\u00a0F, Balestrini\u00a0D et al (2015) Stereotactic radiotherapy in the treatment of lung metastases from bone and soft-tissue sarcomas. Anticancer Res 35(10):5581\u20135586","journal-title":"Anticancer Res"},{"issue":"2","key":"2086_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jrr\/rrab118","volume":"63","author":"Q Lin","year":"2022","unstructured":"Lin\u00a0Q, Zhou\u00a0N, Zhu\u00a0X et al (2022) Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a\u00a0retrospective analysis. J\u00a0Radiat Res 63(2):272\u2013280. https:\/\/doi.org\/10.1093\/jrr\/rrab118","journal-title":"J Radiat Res"},{"issue":"11","key":"2086_CR9","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1002\/cncr.26611","volume":"118","author":"JK Salama","year":"2012","unstructured":"Salama\u00a0JK, Hasselle\u00a0MD, Chmura\u00a0SJ et\u00a0al (2012) Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a\u00a0dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 118(11):2962\u20132970. https:\/\/doi.org\/10.1002\/cncr.26611","journal-title":"Cancer"},{"key":"2086_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2017.01.003","volume":"123","author":"S Tanadini-Lang","year":"2017","unstructured":"Tanadini-Lang\u00a0S, Rieber\u00a0J, Filippi\u00a0AR et al (2017) Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. Radiother Oncol 123:182\u2013188. https:\/\/doi.org\/10.1016\/j.radonc.2017.01.003","journal-title":"Radiother Oncol"},{"issue":"1","key":"2086_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13014-020-01537-z","volume":"15","author":"S Baker","year":"2020","unstructured":"Baker\u00a0S, Bakunina\u00a0K, Duijm\u00a0M et al (2020) Development and external validation of a\u00a0nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer. Radiat Oncol 15(1):89. https:\/\/doi.org\/10.1186\/s13014-020-01537-z","journal-title":"Radiat Oncol"},{"issue":"2","key":"2086_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/jjco\/hyx179","volume":"48","author":"L Ye","year":"2018","unstructured":"Ye\u00a0L, Shi\u00a0S, Zeng\u00a0Z et al (2018) Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy. Jpn J Clin Oncol 48(2):160\u2013166. https:\/\/doi.org\/10.1093\/jjco\/hyx179","journal-title":"Jpn J Clin Oncol"},{"key":"2086_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin\u00a0P, Rios-Velazquez\u00a0E, Leijenaar\u00a0R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441\u2013446. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.036","journal-title":"Eur J Cancer"},{"key":"2086_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/jpm13020225","volume":"13","author":"M Gabelloni","year":"2023","unstructured":"Gabelloni\u00a0M, Faggioni\u00a0L, Fusco\u00a0R et\u00a0al (2023) Radiomics in lung metastases: a systematic review. J\u00a0Pers 13:225. https:\/\/doi.org\/10.3390\/jpm13020225","journal-title":"J Pers"},{"issue":"10","key":"2086_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00066-019-01542-6","volume":"196","author":"D Franceschini","year":"2020","unstructured":"Franceschini\u00a0D, Cozzi\u00a0L, De Rose\u00a0F et al (2020) A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. Strahlenther Onkol 196(10):922\u2013931. https:\/\/doi.org\/10.1007\/s00066-019-01542-6","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"2086_CR16","doi-asserted-by":"publisher","first-page":"025007","DOI":"10.1088\/1361-6560\/aaf5a5","volume":"64","author":"KJ Lafata","year":"2019","unstructured":"Lafata\u00a0KJ, Hong\u00a0JC, Geng\u00a0R et al (2019) Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Phys Med Biol 64(2):25007. https:\/\/doi.org\/10.1088\/1361-6560\/aaf5a5","journal-title":"Phys Med Biol"},{"issue":"1","key":"2086_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13014-017-0892-y","volume":"12","author":"Q Li","year":"2017","unstructured":"Li\u00a0Q, Kim\u00a0J, Balagurunathan\u00a0Y et al (2017) CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy. Radiat Oncol 12(1):158. https:\/\/doi.org\/10.1186\/s13014-017-0892-y","journal-title":"Radiat Oncol"},{"issue":"1","key":"2086_CR18","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41598-018-22357-y","volume":"8","author":"A Oikonomou","year":"2018","unstructured":"Oikonomou\u00a0A, Khalvati\u00a0F, Tyrrell\u00a0PN et\u00a0al (2018) Radiomics analysis at PET\/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy. Sci Rep 8(1):4003. https:\/\/doi.org\/10.1038\/s41598-018-22357-y","journal-title":"Sci Rep"},{"issue":"2","key":"2086_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.radonc.2016.05.024.","volume":"120","author":"E Huynh","year":"2016","unstructured":"Huynh\u00a0E, Coroller\u00a0TP, Narayan\u00a0V et al (2016) CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol 120(2):258\u2013266. https:\/\/doi.org\/10.1016\/j.radonc.2016.05.024","journal-title":"Radiother Oncol"},{"issue":"2","key":"2086_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.radonc.2018.06.025","volume":"129","author":"H Li","year":"2018","unstructured":"Li\u00a0H, Galperin-Aizenberg\u00a0M, Pryma\u00a0D et al (2018) Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Radiother Oncol 129(2):218\u2013226. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.025","journal-title":"Radiother Oncol"},{"issue":"8","key":"2086_CR21","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1002\/mp.12309","volume":"44","author":"Q Li","year":"2017","unstructured":"Li\u00a0Q, Kim\u00a0J, Balagurunathan\u00a0Y et al (2017) Imaging features from pretreatment CT scans are associated with clinical outcomes in non-small cell lung cancer patients treated with stereotactic body radiotherapy. Med Phys 44(8):4341\u20134349. https:\/\/doi.org\/10.1002\/mp.12309","journal-title":"Med Phys"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00066-019-01452-7","volume":"195","author":"K Bousabarah","year":"2019","unstructured":"Bousabarah\u00a0K, Temming\u00a0S, Hoevels\u00a0M et al (2019) Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy. Strahlenther Onkol 195:830\u2013842. https:\/\/doi.org\/10.1007\/s00066-019-01452-7","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"2086_CR23","doi-asserted-by":"publisher","first-page":"e0217536","DOI":"10.1371\/journal.pone.0217536","volume":"14","author":"JE van Timmeren","year":"2019","unstructured":"van Timmeren\u00a0JE, Carvalho\u00a0S, Leijenaar\u00a0RTH et al (2019) Challenges and caveats of a\u00a0multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET\/CT radiomics. PLoS ONE 14(6):e217536. https:\/\/doi.org\/10.1371\/journal.pone.0217536","journal-title":"PLoS ONE"},{"issue":"4","key":"2086_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3857\/roj.2021.00311","volume":"39","author":"BMF Cheung","year":"2021","unstructured":"Cheung\u00a0BMF, Lau\u00a0KS, Lee\u00a0VHF et al (2021) Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases. Radiat Oncol\u00a0J 39(4):254\u2013264. https:\/\/doi.org\/10.3857\/roj.2021.00311","journal-title":"Radiat Oncol J"},{"key":"2086_CR25","doi-asserted-by":"publisher","first-page":"20180422","DOI":"10.1259\/bjr.20180422","volume":"91","author":"F Deodato","year":"2019","unstructured":"Deodato\u00a0F, Macchia\u00a0G, Cilla\u00a0S et al (2019) Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial. Br J Radiol 91:20180422. https:\/\/doi.org\/10.1259\/bjr.20180422","journal-title":"Br J Radiol"},{"issue":"3","key":"2086_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse\u00a0P, Arbuck\u00a0SG, Eisenhauer\u00a0EA et\u00a0al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J\u00a0Natl Cancer Inst 92(3):205\u2013216. https:\/\/doi.org\/10.1093\/jnci\/92.3.205","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"2086_CR27","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJ Van Griethuysen","year":"2017","unstructured":"Van Griethuysen\u00a0JJ, Fedorov\u00a0A, Parmar\u00a0C et\u00a0al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77(21):e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Can Res"},{"issue":"2","key":"2086_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg\u00a0A, Vallieres\u00a0M, Abdalah\u00a0MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2):328\u2013338. https:\/\/doi.org\/10.1148\/radiol.2020191145","journal-title":"Radiology"},{"issue":"1\u20132","key":"2086_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000487440","volume":"85","author":"VML de Sousa","year":"2018","unstructured":"de Sousa\u00a0VML, Carvalho\u00a0L (2018) Heterogeneity in lung cancer. Pathobiology 85(1\u20132):96\u2013107. https:\/\/doi.org\/10.1159\/000487440","journal-title":"Pathobiology"},{"key":"2086_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinimag.2020.12.017","volume":"74","author":"JR Ferreira Junior","year":"2021","unstructured":"Ferreira Junior\u00a0JR, Koenigkam-Santos\u00a0M, de Vita Graves\u00a0C et al (2021) Quantifying intratumor heterogeneity of lung neoplasms with radiomics. Clin Imaging 74:27\u201330. https:\/\/doi.org\/10.1016\/j.clinimag.2020.12.017","journal-title":"Clin Imaging"},{"issue":"11","key":"2086_CR31","doi-asserted-by":"publisher","first-page":"e0206108","DOI":"10.1371\/journal.pone.0206108","volume":"13","author":"TH Dou","year":"2018","unstructured":"Dou\u00a0TH, Coroller\u00a0TP, van Griethuysen\u00a0JJM et\u00a0al (2018) Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS ONE 13(11):e206108. https:\/\/doi.org\/10.1371\/journal.pone.0206108","journal-title":"PLoS ONE"},{"key":"2086_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/14737140.2020.1823223","volume":"20","author":"E Voulaz","year":"2020","unstructured":"Voulaz\u00a0E, Novellis\u00a0P, Rossetti\u00a0F et al (2020) Distinguishing multiple lung primaries from intra-pulmonary metastases and treatment implications. Expert Rev Anticancer Ther 20:985\u2013995. https:\/\/doi.org\/10.1080\/14737140.2020.1823223","journal-title":"Expert Rev Anticancer Ther"},{"key":"2086_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00066-020-01625-9","volume":"196","author":"M Avanzo","year":"2020","unstructured":"Avanzo\u00a0M, Stancanello\u00a0J, Pirrone\u00a0G et\u00a0al (2020) Radiomics and deep learning in lung cancer. Strahlenther Onkol 196:879\u2013887. https:\/\/doi.org\/10.1007\/s00066-020-01625-9","journal-title":"Strahlenther Onkol"},{"key":"2086_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.radonc.2019.08.003","volume":"143","author":"A Davey","year":"2019","unstructured":"Davey\u00a0A, van Herk\u00a0M, Faivre-Finn\u00a0C et al (2019) Is tumour sphericity an important prognostic factor in patients with lung cancer? Radiother Oncol 143:73\u201380. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.003","journal-title":"Radiother Oncol"},{"key":"2086_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2013.08.028","volume":"109","author":"FJ Salguero","year":"2013","unstructured":"Salguero\u00a0FJ, Belderbos\u00a0JSA, Rossi\u00a0MMG et al (2013) Microscopic disease extensions as a\u00a0risk factor for loco-regional recurrence of NSCLC after SBRT. Radiother Oncol 109:26\u201331. https:\/\/doi.org\/10.1016\/j.radonc.2013.08.028","journal-title":"Radiother Oncol"},{"key":"2086_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.radonc.2016.04.004","volume":"119","author":"TP Coroller","year":"2016","unstructured":"Coroller\u00a0TP, Agrawal\u00a0V, Narayan\u00a0V et al (2016) Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol 119:480\u2013486. https:\/\/doi.org\/10.1016\/j.radonc.2016.04.004","journal-title":"Radiother Oncol"},{"key":"2086_CR37","doi-asserted-by":"publisher","first-page":"e88598","DOI":"10.1371\/journal.pone.0088598","volume":"9","author":"Y Chong","year":"2014","unstructured":"Chong\u00a0Y, Kim\u00a0JH, Lee\u00a0HY et al (2014) Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy? Plos One 9:e88598. https:\/\/doi.org\/10.1371\/journal.pone.0088598","journal-title":"Plos One"},{"key":"2086_CR38","doi-asserted-by":"publisher","first-page":"109874","DOI":"10.1016\/j.ejrad.2021.109874","volume":"142","author":"D Caruso","year":"2021","unstructured":"Caruso\u00a0D, Zerunian\u00a0M, Daffina\u00a0J et\u00a0al (2021) Radiomics and functional imaging in lung cancer: the importance of radiological heterogeneity beyond FDG PET\/CT and lung biopsy. Eur J Radiol 142:109874. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109874","journal-title":"Eur J Radiol"},{"key":"2086_CR39","doi-asserted-by":"publisher","first-page":"e100244","DOI":"10.1371\/journal.pone.0100244","volume":"9","author":"GJ Weiss","year":"2014","unstructured":"Weiss\u00a0GJ, Ganeshan\u00a0B, Miles\u00a0KA et al (2014) Noninasive image texture analysis differentiates Kras mutation from pan-wildtype NSCLC and is prognostic. Plos One 9:e100244. https:\/\/doi.org\/10.1371\/journal.pone.0100244","journal-title":"Plos One"},{"key":"2086_CR40","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1245\/s10434-012-2754-z","volume":"20","author":"JL Guan","year":"2013","unstructured":"Guan\u00a0JL, Zhong\u00a0WZ, An\u00a0SJ et al (2013) KRAS mutation in patients with lung cancer: a\u00a0predictor for poor prognosis but not for EGFR-KIs or chemotherapy. Ann Surg Oncol 20:1381\u20131388. https:\/\/doi.org\/10.1245\/s10434-012-2754-z","journal-title":"Ann Surg Oncol"},{"key":"2086_CR41","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1158\/0008-5472.CAN-16-0808","volume":"77","author":"M Wang","year":"2017","unstructured":"Wang\u00a0M, Han\u00a0J, Marcar\u00a0L et al (2017) Radiation resistance in KRAS mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway. Cancer Res 77:2018\u20132028. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0808","journal-title":"Cancer Res"},{"issue":"1","key":"2086_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2478\/v10019-012-0009-z","volume":"46","author":"D Muenzel","year":"2012","unstructured":"Muenzel\u00a0D, Engels\u00a0HP, Bruegel\u00a0M et al (2012) Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1. Radiol Oncol 46(1):8\u201318. https:\/\/doi.org\/10.2478\/v10019-012-0009-z","journal-title":"Radiol Oncol"},{"issue":"2","key":"2086_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1148\/radiology.13122665","volume":"269","author":"A McErlean","year":"2013","unstructured":"McErlean\u00a0A, Panicek\u00a0DM, Zabor\u00a0EC et al (2013) Intra- and interobserver variability in CT measurements in oncology. Radiology 269(2):451\u2013459. https:\/\/doi.org\/10.1148\/radiology.13122665","journal-title":"Radiology"},{"issue":"9","key":"2086_CR44","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1002\/mp.14308","volume":"47","author":"N Garau","year":"2020","unstructured":"Garau\u00a0N, Paganelli\u00a0C, Summers\u00a0P et al (2020) External validation of radiomics-based predictive models in low-dose CT screening for early lung cancer diagnosis. Med Phys 47(9):4125\u20134136. https:\/\/doi.org\/10.1002\/mp.14308","journal-title":"Med Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:03:55Z","timestamp":1687277035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02086-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Cilla, D.\u00a0Pistilli, C.\u00a0Romano, G.\u00a0Macchia, A.\u00a0Pierro, A.\u00a0Arcelli, M.\u00a0Buwenge, A.G.\u00a0Morganti, and F.\u00a0Deodato declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study received approval at the Gemelli Molise Hospital Institutional Review Board. Informed consent: not applicable; patients signed informed consent to the treatment procedure, but the study was retrospective.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}